Lacosamide Ucb

Lacosamide, the active ingredient in Lacosamide Ucb, is an anti‑epileptic drug presented as an oral tablet for oral use. It is indicated for the adjunctive treatment of partial‑onset seizures in patients with epilepsy.

GNH USA supplies Lacosamide Ucb as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lacosamide is an anti‑epileptic medication used to manage seizure disorders.

- Partial‑onset seizures: provides adjunctive seizure control in patients with epilepsy.

Lacosamide may cause a range of adverse reactions.

Common Side Effects: - Dizziness: mild vertigo or light‑headedness. - Nausea: upset stomach or feeling sick. - Fatigue: unusual tiredness. - Headache: mild to moderate pain.

Serious or Rare Side Effects: - Suicidal thoughts: emergence of depressive symptoms or suicidal ideation. - Severe skin reactions: rash, Stevens‑Johnson syndrome. - Cardiac arrhythmia: irregular heartbeat or palpitations.

When prescribing Lacosamide, consider the following precautions.

- Assess renal function: adjust dosing if impairment is present. - Monitor mood changes: watch for depression or suicidal ideation. - Avoid abrupt discontinuation: taper under medical supervision. - Use caution in hepatic impairment: evaluate liver function before initiation. - Store at room temperature: keep in the original pack, protect from moisture.

Lacosamide can interact with several medicines; awareness of the interaction level is essential.

Major Interactions (Avoid): - Strong CYP3A4 inducers (e.g., carbamazepine, phenytoin): may lower lacosamide plasma concentrations. - Other sodium‑channel blockers: increased risk of central nervous system depression. - QT‑prolonging agents: potential for additive cardiac arrhythmia risk.

Moderate Interactions (Monitor Closely): - Oral contraceptives: efficacy may be reduced, requiring additional contraceptive measures. - Anticoagulants (e.g., warfarin): may necessitate INR monitoring and dose adjustment.